Drug class
Proteasome Inhibitor
Mechanism of action
Proteasome Inhibitors
General use cases
- Multiple Myeloma
- patients with multiple myeloma who have received at least one prior therapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
